Nicola Mikulcik Ohrner
Corporate Officer/Principal chez FORMYCON AG
Profil
Nicola Mikulcik Ohrner is currently holding three positions in the biotech industry.
He is the Chief Executive Officer of bioeq GmbH, a Director at Bioeq AG, and the Chief Business Officer at Formycon AG.
Postes actifs de Nicola Mikulcik Ohrner
Sociétés | Poste | Début |
---|---|---|
FORMYCON AG | Corporate Officer/Principal | 01/06/2022 |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Chief Executive Officer | - |
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Director/Board Member | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
FORMYCON AG | Health Technology |
Entreprise privées | 2 |
---|---|
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Health Technology |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Health Technology |